Integer Holdings Corp ITGR
NYSE · XNYS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
3.52
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $1.9B | $102.8M | $500.4M | $105.1M | $1.7B |
| 2024 | $1.7B | $119.9M | $459.0M | $99.8M | $1.6B |
| 2023 | $1.6B | $90.7M | $409.9M | $60.3M | $1.5B |
| 2022 | $1.3B | $66.4M | $345.8M | $41.7M | $1.4B |
| 2021 | $1.2B | $96.8M | $337.0M | $103.2M | $1.4B |
| 2020 | $1.1B | $77.3M | $285.7M | $134.5M | $1.3B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.52 (safe)
- Working capital / assets 0.158
- Retained earnings / assets 0.291
- EBIT / assets 0.065
- Equity / liabilities 1.05
Source: SEC EDGAR filings · CIK 0001114483 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.